Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathee Till

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical TrialsCatherine M Tangen, Phyllis J Goodman, Cathee Till, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical TrialsDawn L Hershman, Cathee Till, Sherry Shen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 9, 2022
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention TrialJeannette M Schenk, Cathee Till, Marian L Neuhouser, et al.
European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.
Journal of the National Cancer Institute|March 22, 2023
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patientsJoseph M Unger, Cathee Till, Jessica P Hwang, et al.
Journal of the National Cancer Institute|October 6, 2020
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical TrialsJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
Population Health Management|January 10, 2023
Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention TrialMatthew C Rock, Riha Vaidya, Cathee Till, et al.
Breast Cancer Research and Treatment|April 20, 2020
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trialsDawn L Hershman, Cathee Till, Jason D Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical TrialsDawn L Hershman, Cathee Till, Jason D Wright, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical TrialsCatherine M Tangen, Phyllis J Goodman, Cathee Till, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical TrialsDawn L Hershman, Cathee Till, Sherry Shen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 9, 2022
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention TrialJeannette M Schenk, Cathee Till, Marian L Neuhouser, et al.
European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.
Journal of the National Cancer Institute|March 22, 2023
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patientsJoseph M Unger, Cathee Till, Jessica P Hwang, et al.
Journal of the National Cancer Institute|October 6, 2020
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical TrialsJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
Population Health Management|January 10, 2023
Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention TrialMatthew C Rock, Riha Vaidya, Cathee Till, et al.
Breast Cancer Research and Treatment|April 20, 2020
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trialsDawn L Hershman, Cathee Till, Jason D Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical TrialsDawn L Hershman, Cathee Till, Jason D Wright, et al.
Pageof 7